Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan

详细信息    查看全文

• 作者：Lung-An Hsu ; Yu-Lin Ko ; Chi-Jen Chang ; Chiao-Feng Hu ; Semon Wu ; Ming-Sheng Teng ; Chun-Li Wang ; Wan-Jing Ho ; Yu-Shien Ko ; Tsu-Shiu Hsu and Ying-Shiung Lee
• 刊名：Atherosclerosis
• 出版年：2006
• 出版时间：March 2006
• 年：2006
• 卷：185
• 期：1
• 页码：143-149
• 全文大小：100 K

文摘

Recently, a T/C polymorphism of the promoter region of the APOA5 gene at position -1131 and a G/T polymorphism at position 553 were found to be associated with increased levels of plasma triglyceride. Triglyceride plays a role in coronary artery disease (CAD), so this case–control study tested for a possible link between these two APOA5 polymorphisms, their common haplotypes and the risk of CAD. The subjects included 211 CAD patients and 677 unrelated controls. A significantly higher level of triglycerides and a lower level of high-density lipoprotein cholesterol (HDL-C) were noted for carriers with -1131C than for non-carriers (P < 0.001 and 0.013, respectively) among controls. Plasma triglyceride levels were significantly higher (P = 0.014) in controls with genotypes that contained the c.553T allele than in homozygotes for the G allele. Subjects homozygous for the wild-type haplotype had significantly lower triglyceride levels and higher HDL-C levels than subjects with all other haplotype pairs. The -1131C homozygous carriers and c.553T heterozygous carriers were found more frequently in 211 patients with CAD than in the 317 age/sex-matched controls (P = 0.008 and 0.023, respectively) in univariate analysis. The significant association between c.553T allele carriers with CAD remained in multivariate regression analysis (OR, 1.79; CI, 1.07–3.00; P = 0.028), after adjustments were made for other risk factors. Notably, haplotype analysis further verified that the APOA5 -1131C and c.553T bi-loci haplotype was significantly overpresented in CAD, as compared to the controls. These results indicate that the variants of APOA5 gene modulate plasma triglyceride and may use them to predict CAD susceptibility in Taiwanese Chinese.